Epigenetic perspectives in systemic lupus erythematosus: Pathogenesis, biomarkers, and therapeutic potentials

Clinical Reviews in Allergy and Immunology

Volumn 39, Issue 1, 2010, Pages 3-9

  Zhao, Sha ^a   Long, Hai ^a   Lu, Qianjin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

DNA methylation; Histone modification; MicroRNA; Systemic lupus erythematosus (SLE)

Indexed keywords

4 PHENYLBUTYRIC ACID; CD11 ANTIGEN; CD40 LIGAND; CD70 ANTIGEN; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE H3; HISTONE H4; HISTONE METHYLTRANSFERASE; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PERFORIN; PROTEIN SUV39H2; SIRTUIN 1; TRANSCRIPTION FACTOR EZH2; TRICHOSTATIN A; UNCLASSIFIED DRUG; VORINOSTAT;

ACETYLATION; APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DNA METHYLATION; DOWN REGULATION; DRUG EFFECT; EPIGENETICS; GENE ACTIVITY; GENE EXPRESSION; HUMAN; IMMUNOCOMPETENT CELL; NONHUMAN; PATHOGENESIS; PROTEIN METHYLATION; PROTEIN MODIFICATION; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; UPREGULATION;

ANIMALS; AUTOANTIBODIES; BIOLOGICAL MARKERS; CYTOTOXICITY, IMMUNOLOGIC; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICRORNAS; PROGNOSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 77954083521     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-009-8165-7     Document Type: Review

References (70)

1. EK Wakeland K Liu RR Graham TW Behrens 2001 Delineating the genetic basis of systemic lupus erythematosus Immunity 15 397 408 10.1016/S1074-7613(01) 00201-1 11567630 1:CAS:528:DC%2BD3MXntlSntLk%3D (Pubitemid 32907387)
2. BP Tsao 2003 The genetics of human systemic lupus erythematosus Trends Immunol 24 595 602 10.1016/j.it.2003.09.006 14596884 1:CAS:528: DC%2BD3sXosVyis7g%3D (Pubitemid 37338528)
3. GS Cooper KM Gilbert EL Greidinger, et al. 2008 Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease Environ Health Perspect 116 695 702 10.1289/ehp.11092 18560522 1:CAS:528:DC%2BD1cXnvVCrtrk%3D (Pubitemid 351943922)
4. Y Pan AH Sawalha 2009 Epigenetic regulation and the pathogenesis of systemic lupus erythematosus Transl Res 153 4 10 10.1016/j.trsl.2008.10.007 19100952 1:CAS:528:DC%2BD1cXhsFagsLjO
5. B Richardson L Scheinbart J Strahler, et al. 1990 Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis Arthritis Rheum 33 1665 1673 10.1002/art.1780331109 2242063 1:CAS:528: DyaK38XjvFWjtg%3D%3D
6. A Corvetta R Della Bitta MM Luchetti G Pomponio 1991 5-Methylcytosine content of DNA in blood, synovial mononuclear cells and synovial tissue from patients affected by autoimmune rheumatic diseases J Chromatogr 566 481 491 10.1016/0378-4347(91)80265-E 1939459 1:CAS:528:DyaK3MXks1OksLs%3D
7. RL Yung J Quddus CE Chrisp KJ Johnson BC Richardson 1995 Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo J Immunol 154 3025 3035 7533191 1:CAS:528:DyaK2MXktlGhtLY%3D
8. J Quddus KJ Johnson J Gavalchin, et al. 1993 Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice J Clin Invest 92 38 53 10.1172/JCI116576 7686923 1:CAS:528:DyaK3sXlsFajt7o%3D
9. E Cornacchia J Golbus J Maybaum, et al. 1988 Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity J Immunol 140 2197 2200 3258330 1:CAS:528:DyaL1cXhsl2ru70%3D
10. B Richardson 2007 Primer: epigenetics of autoimmunity Nat Clin Pract Rheumatol 3 521 527 10.1038/ncprheum0573 17762851 1:CAS:528:DC%2BD2sXps12gtrg%3D (Pubitemid 47351397)
11. BC Richardson JR Strahler TS Pivirotto, et al. 1992 Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus Arthritis Rheum 35 647 662 10.1002/art.1780350608 1376122 1:CAS:528:DyaK38Xlt12ksbg%3D
12. Q Lu M Kaplan D Ray, et al. 2002 Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus Arthritis Rheum 46 1282 1291 10.1002/art.10234 12115234 1:CAS:528:DC%2BD38XksVynsrs%3D (Pubitemid 34525836)
13. MJ Kaplan Q Lu A Wu J Attwood B Richardson 2004 Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells J Immunol 172 3652 3661 15004168 1:CAS:528:DC%2BD2cXhvVKisrw%3D
14. Q Lu A Wu D Ray, et al. 2003 DNA methylation and chromatin structure regulate T cell perforin gene expression J Immunol 170 5124 5132 12734359 1:CAS:528:DC%2BD3sXjsVGqsb4%3D
15. Q Lu A Wu BC Richardson 2005 Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs J Immunol 174 6212 6219 15879118 1:CAS:528: DC%2BD2MXjvV2mtLo%3D
16. K Oelke Q Lu D Richardson, et al. 2004 Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors Arthritis Rheum 50 1850 1860 10.1002/art.20255 15188362 1:CAS:528:DC%2BD2cXlsFaqtLc%3D (Pubitemid 38725098)
17. Q Lu A Wu L Tesmer, et al. 2007 Demethylation of CD40LG on the inactive X in T cells from women with lupus J Immunol 179 6352 6358 17947713 1:CAS:528:DC%2BD2sXhtFyksr3E
18. XB Mi FQ Zeng 2008 Hypomethylation of interleukin-4 and -6 promoters in T cells from systemic lupus erythematosus patients Acta Pharmacol Sin 29 105 112 10.1111/j.1745-7254.2008.00739.x 18158872 1:CAS:528:DC%2BD1cXovVKgug%3D%3D
19. E Ballestar M Esteller BC Richardson 2006 The epigenetic face of systemic lupus erythematosus J Immunol 176 7143 7147 16751355 1:CAS:528: DC%2BD28Xlt1CltLs%3D
20. ZK Wen W Xu L Xu, et al. 2007 DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice Rheumatology (Oxford) 46 1796 1803 10.1093/ rheumatology/kem275 1:CAS:528:DC%2BD2sXhtlKmtbbP (Pubitemid 350168294)
21. B Qiao J Wu YW Chu, et al. 2005 Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA Rheumatology (Oxford) 44 1108 1114 10.1093/rheumatology/ keh656 1:CAS:528:DC%2BD2MXovVKrtb4%3D (Pubitemid 41236016)
22. AH Sawalha 2008 Epigenetics and T-cell immunity Autoimmunity 41 245 252 10.1080/08916930802024145 18432405 1:CAS:528:DC%2BD1cXltFCmurc%3D (Pubitemid 351593855)
23. Y Luo Y Li Y Su, et al. 2008 Abnormal DNA methylation in T cells from patients with subacute cutaneous lupus erythematosus Br J Dermatol 159 827 833 10.1111/j.1365-2133.2008.08758.x 18644019 1:CAS:528:DC%2BD1cXhtlGitrvE
24. C Deng MJ Kaplan J Yang, et al. 2001 Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients Arthritis Rheum 44 397 407 10.1002/1529-0131(200102)44:2<397:: AID-ANR59>3.0.CO;2-N 11229472 1:CAS:528:DC%2BD3MXitlCgurw%3D (Pubitemid 32207034)
25. LS Scheinbart MA Johnson LA Gross SR Edelstein BC Richardson 1991 Procainamide inhibits DNA methyltransferase in a human T cell line J Rheumatol 18 530 534 2066944 1:CAS:528:DyaK3MXks1Cgs7c%3D
26. E Balada J Ordi-Ros S Serrano-Acedo, et al. 2008 Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus Immunology 124 339 347 10.1111/j.1365-2567.2007. 02771.x 18194272 1:CAS:528:DC%2BD1cXotVehtrg%3D (Pubitemid 351793466)
27. C Deng Q Lu Z Zhang, et al. 2003 Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling Arthritis Rheum 48 746 756 10.1002/art.10833 12632429 1:CAS:528:DC%2BD3sXislKgur4%3D (Pubitemid 36302012)
28. AH Sawalha M Jeffries R Webb, et al. 2008 Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients Genes Immun 9 368 378 10.1038/gene.2008.29 18523434 1:CAS:528:DC%2BD1cXms1equrs%3D (Pubitemid 351791493)
29. G Gorelik JY Fang A Wu AH Sawalha B Richardson 2007 Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus J Immunol 179 5553 5563 17911642 1:CAS:528:DC%2BD2sXhtFWit77P
30. A Miyamoto K Nakayama H Imaki, et al. 2002 Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta Nature 416 865 869 10.1038/416865a 11976687 1:CAS:528:DC%2BD38XjtFyksbc%3D (Pubitemid 34453744)
31. BA Garcia SA Busby J Shabanowitz DF Hunt N Mishra 2005 Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition J Proteome Res 4 2032 2042 10.1021/pr050188r 16335948 1:CAS:528:DC%2BD2MXhtFynu7bE (Pubitemid 41814269)
32. N Hu X Qiu Y Luo, et al. 2008 Abnormal histone modification patterns in lupus CD4+ T cells J Rheumatol 35 804 810 18398941 1:CAS:528: DC%2BD1cXntVOmur0%3D
33. N Mishra CM Reilly DR Brown P Ruiz GS Gilkeson 2003 Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse J Clin Invest 111 539 552 12588892 1:CAS:528:DC%2BD3sXhtlGis7Y%3D
34. CM Reilly N Mishra JM Miller, et al. 2004 Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid J Immunol 173 4171 4178 15356168 1:CAS:528:DC%2BD2cXnsVWrsrg%3D
35. N Mishra DR Brown IM Olorenshaw GM Kammer 2001 Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells Proc Natl Acad Sci U S A 98 2628 2633 10.1073/pnas.051507098 11226290 1:CAS:528:DC%2BD3MXhslKmsbw%3D (Pubitemid 32209533)
36. X Nan HH Ng CA Johnson, et al. 1998 Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex Nature 393 386 389 10.1038/30764 9620804 1:CAS:528:DyaK1cXjsFKgurc%3D (Pubitemid 28269714)
37. F Fuks PJ Hurd D Wolf, et al. 2003 The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation J Biol Chem 278 4035 4040 10.1074/jbc.M210256200 12427740 1:CAS:528:DC%2BD3sXot1yisg%3D%3D (Pubitemid 36801137)
38. F Fuks WA Burgers A Brehm L Hughes-Davies T Kouzarides 2000 DNA methyltransferase Dnmt1 associates with histone deacetylase activity Nat Genet 24 88 91 10.1038/71750 10615135 1:CAS:528:DC%2BD3cXks1eltg%3D%3D (Pubitemid 30041428)
39. DP Bartel CZ Chen 2004 Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs Nat Rev Genet 5 396 400 10.1038/nrg1328 15143321 1:CAS:528:DC%2BD2cXjsl2hsr0%3D
40. QJ Li J Chau PJ Ebert, et al. 2007 miR-181a is an intrinsic modulator of T cell sensitivity and selection Cell 129 147 161 10.1016/j.cell.2007.03.008 17382377 1:CAS:528:DC%2BD2sXkvVeltLc%3D (Pubitemid 46507589)
41. A Rodriguez E Vigorito S Clare, et al. 2007 Requirement of bic/microRNA-155 for normal immune function Science 316 608 611 10.1126/science.1139253 17463290 1:CAS:528:DC%2BD2sXksFeksbg%3D (Pubitemid 46683148)
42. E Vigorito KL Perks C Abreu-Goodger, et al. 2007 microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells Immunity 27 847 859 10.1016/j.immuni.2007.10.009 18055230 1:CAS:528:DC%2BD1cXotFWr (Pubitemid 350258623)
43. K Calame 2007 MicroRNA-155 function in B Cells Immunity 27 825 827 10.1016/j.immuni.2007.11.010 18093533 1:CAS:528:DC%2BD1cXotFWg (Pubitemid 350251220)
44. LF Lu TH Thai DP Calado, et al. 2009 Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein Immunity 30 80 91 10.1016/j.immuni.2008.11.010 19144316 1:CAS:528:DC%2BD1MXhtlCnsLs%3D
45. KD Taganov MP Boldin KJ Chang D Baltimore 2006 NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses Proc Natl Acad Sci U S A 103 12481 12486 10.1073/pnas.0605298103 16885212 1:CAS:528:DC%2BD28Xos1Kqt7g%3D (Pubitemid 44267285)
46. B Zhou S Wang C Mayr DP Bartel HF Lodish 2007 miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely Proc Natl Acad Sci U S A 104 7080 7085 10.1073/pnas.0702409104 17438277 1:CAS:528:DC%2BD2sXls1KrtLY%3D (Pubitemid 47186012)
47. JB Johnnidis MH Harris RT Wheeler, et al. 2008 Regulation of progenitor cell proliferation and granulocyte function by microRNA-223 Nature 451 1125 1129 10.1038/nature06607 18278031 1:CAS:528:DC%2BD1cXisFWjtrY%3D (Pubitemid 351317447)
48. JT Mendell 2008 miRiad roles for the miR-17-92 cluster in development and disease Cell 133 217 222 10.1016/j.cell.2008.04.001 18423194 1:CAS:528:DC%2BD1cXltlWnurY%3D (Pubitemid 351508308)
49. C Xiao L Srinivasan DP Calado, et al. 2008 Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes Nat Immunol 9 405 414 10.1038/ni1575 18327259 1:CAS:528:DC%2BD1cXjtlGmsLo%3D (Pubitemid 351405110)
50. J Stanczyk DM Pedrioli F Brentano, et al. 2008 Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis Arthritis Rheum 58 1001 1009 10.1002/art.23386 18383392 (Pubitemid 351564001)
51. RJ Rigby CG Vinuesa 2008 SiLEncing SLE: the power and promise of small noncoding RNAs Curr Opin Rheumatol 20 526 531 10.1097/BOR.0b013e328304b45e 18698172 1:CAS:528:DC%2BD1cXpvFygtbo%3D
52. Y Dai YS Huang M Tang, et al. 2007 Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients Lupus 16 939 946 10.1177/0961203307084158 18042587 1:CAS:528: DC%2BD1cXhtlOqs7w%3D
53. Y Dai W Sui H Lan, et al. 2008 Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients Rheumatol Int 29 7 749 54 10.1007/s00296-008-0758-6 18998140 1:CAS:528:DC%2BD1MXlt1Kjtbg%3D
54. D Yu AH Tan X Hu, et al. 2007 Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA Nature 450 299 303 10.1038/nature06253 18172933 1:CAS:528:DC%2BD2sXht1yntrjF (Pubitemid 350100535)
55. M Fabbri R Garzon A Cimmino, et al. 2007 MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B Proc Natl Acad Sci U S A 104 15805 15810 10.1073/pnas.0707628104 17890317 (Pubitemid 350035380)
56. L Tuddenham G Wheeler S Ntounia-Fousara, et al. 2006 The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells FEBS Lett 580 4214 4217 10.1016/j.febslet.2006.06.080 16828749 1:CAS:528:DC%2BD28XntV2ru7k%3D (Pubitemid 44037596)
57. GK Scott MD Mattie CE Berger SC Benz CC Benz 2006 Rapid alteration of microRNA levels by histone deacetylase inhibition Cancer Res 66 1277 1281 10.1158/0008-5472.CAN-05-3632 16452179 1:CAS:528:DC%2BD28XpsVejtQ%3D%3D (Pubitemid 43259904)
58. Y Saito G Liang G Egger, et al. 2006 Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells Cancer Cell 9 435 443 10.1016/j.ccr.2006.04.020 16766263 1:CAS:528:DC%2BD28Xmt1eksLY%3D (Pubitemid 43832188)
59. Y Wang Y Liang Q Lu 2008 MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases Clin Genet 74 307 315 10.1111/j.1399-0004.2008.01075.x 18713257 1:CAS:528:DC%2BD1cXhsVyms7zN
60. N Arnheim P Calabrese 2009 Understanding what determines the frequency and pattern of human germline mutations Nat Rev Genet 10 478 488 10.1038/nrg2529 19488047 1:CAS:528:DC%2BD1MXnsVWgtLk%3D
61. SP Barros S Offenbacher 2009 Epigenetics: connecting environment and genotype to phenotype and disease J Dent Res 88 400 408 10.1177/0022034509335868 19493882 1:CAS:528:DC%2BD1MXosVemsbk%3D
62. LM Figueiredo GA Cross CJ Janzen 2009 Epigenetic regulation in African trypanosomes: a new kid on the block Nat Rev Microbiol 7 504 513 10.1038/nrmicro2149 19528957 1:CAS:528:DC%2BD1MXntlGns7c%3D
63. A Hewagama B Richardson 2009 The genetics and epigenetics of autoimmune diseases J Autoimmun 33 3 11 10.1016/j.jaut.2009.03.007 19349147 1:CAS:528:DC%2BD1MXms1Wgur4%3D
64. P Invernizzi 2009 Future directions in genetic for autoimmune diseases J Autoimmun 33 1 2 10.1016/j.jaut.2009.03.001 19410428 1:CAS:528: DC%2BD1MXms1Wgtb8%3D
65. P Invernizzi S Pasini C Selmi ME Gershwin M Podda 2009 Female predominance and X chromosome defects in autoimmune diseases J Autoimmun 33 12 16 10.1016/j.jaut.2009.03.005 19356902 1:CAS:528:DC%2BD1MXms1Wgtbo%3D
66. D Larizza V Calcaterra M Martinetti 2009 Autoimmune stigmata in Turner syndrome: when lacks an X chromosome J Autoimmun 33 25 30 10.1016/j.jaut.2009. 03.002 19349146 1:CAS:528:DC%2BD1MXms1Wgtbk%3D
67. L Persani R Rossetti C Cacciatore M Bonomi 2009 Primary ovarian insufficiency: X chromosome defects and autoimmunity J Autoimmun 33 35 41 10.1016/j.jaut.2009.03.004 19346101 1:CAS:528:DC%2BD1MXms1Wgur0%3D
68. AH Sawalha JB Harley RH Scofield 2009 Autoimmunity and Klinefelter's syndrome: when men have two X chromosomes J Autoimmun 33 31 34 10.1016/j.jaut.2009.03.006 19464849 1:CAS:528:DC%2BD1MXms1Wgur8%3D
69. AD Wells 2009 New insights into the molecular basis of T cell anergy: anergy factors, avoidance sensors, and epigenetic imprinting J Immunol 182 7331 7341 10.4049/jimmunol.0803917 19494254 1:CAS:528:DC%2BD1MXmslCgu7g%3D
70. M Zernicka-Goetz SA Morris AW Bruce 2009 Making a firm decision: multifaceted regulation of cell fate in the early mouse embryo Nat Rev Genet 10 467 477 10.1038/nrg2564 19536196 1:CAS:528:DC%2BD1MXnsVWgtLc%3D